Vyleesi (Bremelanotide)
Complete Vyleesi (Bremelanotide) Protocol & Tracking Guide
Vyleesi is the FDA-approved brand of bremelanotide for HSDD in premenopausal women. 1.75mg subcutaneous at least 45 minutes before anticipated sexual activity. Max 1 dose per 24 hours.
🔬 Research✨ Free✓ Updated 2026
Overview
Vyleesi is the FDA-approved brand of bremelanotide for HSDD in premenopausal women. 1.75mg subcutaneous at least 45 minutes before anticipated sexual activity. Max 1 dose per 24 hours.
Track with Shotlee
Log your doses, monitor effects, and optimize your protocol with data — completely free.
Get Shotlee Free